Kesavan Karthikeyan | Assistant Professor
Guru Ghasidas Central University | India

Kesavan Karthikeyan, Assistant Professor, Guru Ghasidas Central University

Dr. K. Kesavan is a well-versed nanotechnologist, with expertise in developing nanoparticulate systems for delivering drugs to eye for the treatment of ocular diseases like glaucoma, uveitis, bacterial keratitis and allergic conjunctivitis. He acquired his B.Pharm from The Tamil Nadu Dr. M.G.R. Medical University, Chennai and M.Pharm in Pharmaceutics from Bharathidasan University, Trichy. He obtained Ph.D from Indian Institute of Technology, Banaras Hindu University (IIT-BHU), Varanasi, and then he joined as Assistant Professor in SLT Institute of Pharmaceutical Sciences, Guru Ghasidas Central University, Bilaspur, C.G. in the year 2012. His group involved in the development of novel drug delivery system as a viable alternative to conventional eye drops due to its ability to enhance bioavailability through its longer precorneal residence time and ability to sustain the release of the drug. Currently, his group working on the development of the mucoadhesive nanoparticulate drug delivery systems for ocular drug delivery, which would offer the advantages of decreased dose and dosage regimen, sustained release, improved patient compliance, and enhanced safety profile. He has published more than 20 papers in reputed peer reviewed international journals. He has presented several papers in various national and international conferences. He extensively review manuscripts for many leading journals including Expert Opin Drug Deliv, Drug Dev Ind Pharm, Int J Pharm, Drug Deliv, Curr eye Res.


Phar-East Day Two @ 15:55

Mucoadhesive nano-carrier as non-viral vector for ocular gene therapy for the management of glaucoma

Glaucoma is the second leading cause of blindness with 60.5 million patients worldwide in 2010, a figure that is expected to increase to 79.6 million by 2020. Find out how gene therapy helps to treat ocular disorders using mucoadhesive nanocarrier as vector for the treatment.

back to speakers